Dr. Barry Sleckman completed his MD and PhD (Immunology) at Harvard Medical School in 1990 followed by an internship and residency in Medicine and a fellowship in Infectious Diseases at the Brigham and Women’s Hospital in Boston. In 1998, after completing a post-doctoral fellowship in Molecular Immunology at Harvard, Dr. Sleckman started his independent laboratory in the Department of Pathology and Immunology at the Washington University School of Medicine (WUSM) in St. Louis. In 2015 he moved to the Department of Pathology at Weill Cornell Medicine and in 2020 he moved to The University of Alabama at Birmingham to become the Director of the O’Neal Comprehensive Cancer Center. His laboratory focuses on elucidating pathways required for immune system development and on understanding DNA damage responses, especially as they apply to cancer and the development of novel cancer therapeutics.
Right Drug, Right Patient, Right TimeFind out more